Tunisia Hechmi Louzir, general manager of the Institut Pasteur in Tunis (IPT), details the crucial role that the IPT plays in the development of the Tunisian health sector, his wide-ranging responsibilities as general manager, the increasing importance of building new partnerships between the private and public sectors, and the Institute’s ambition…
Austria Prof. Dr. Robin Rumler, country manager of Pfizer Austria, discusses the evolution of their operations, especially since taking over the TBE and meningitis vaccine production plant, as well as the challenges facing the entire Austrian healthcare system today. Furthermore, he provides solutions to create a sustainable future for Austrian healthcare,…
Indonesia Omar Luqmaan Harris, GM at GSK Indonesia, discusses the commitment of the Indonesian affiliate to the global organization’s mission, as well as their focus on being the best place to work, with the highest patient focus, and the best customer engagement. Mr. Harris, what have been your main areas of…
Indonesia Ashish D. Pal, President Director at MSD Indonesia, discusses the importance of introducing innovative pharmaceuticals, vaccines and biologics to address significant unmet needs and the strategic importance of the universal healthcare coverage program (JKN) towards meeting the national healthcare goals. Mr. Pal, you have been leading the Indonesian affiliate of…
Mexico Eduardo Arce Parellada, General Manager at Sanofi Pasteur Mexico until March 2017, explains the positive impact that the vaccine against Dengue could generate for the national health system and showcases the positioning of Sanofi Pasteur as the partner of choice for the government in vaccinology, based on its local R&D…
Pharma Daniel Breitenstein, VP and GM of GSK Switzerland, discusses the benefits of GSK’s three-part transaction with Novartis; the importance of respiratory diseases and vaccines for future success; and how the company has changed its business model by no longer paying for physicians to speak on their behalf, setting in process…
Pharma GSK Hungary’s Claire Roger discusses the value of ethical promotion both in improving transparency and benefiting all stakeholders. She further describes the strategic role and economic impact of GSK’s vaccine plant in Gödöllő and growth opportunities in HIV. Given that you’ve only recently arrived in May 2015, Claire, what priorities have been at the…
Thailand Thailand has long been an active participant in vaccine R&D and is increasingly aware of the importance of self-reliance in vaccine production. Through government support and regional cooperation, Thailand is now positioning itself as a regional hub for vaccine research and production. I’m confident Thailand can become the vaccine…
Pharma Roeland Van Dam, CEO of Bilthoven Biologicals, a historical Dutch company which remains at the forefront of vaccine production, explains how being integrated into the Serum Institute of India has helped the company to become profitable and consider ambitious new objectives. Bilthoven Biologicals has a very unique history, having started…
Holland Thijs De Kleer, Managing Director, Saco de Visser, Director Cluster Development, discuss recent developments at the Netherlands largest science park and how Leiden has positioned itself as a leader in early stages of development, which creates a great environment to foster innovation. Leiden lies at the center of the Dutch…
Thailand Pfizer is now the number one pharmaceuticals company in Thailand. We spoke to Christian Malherbe, Country Lead for IndoChina, which includes Myanmar, Laos, and Cambodia, about how he is making the management structure flatter and continuing to bring new medicines to the region. In the future, we see our…
HIV The head of operations of Hetero South Africa talks about the need for a more efficient regulatory system with a fast track process for essential molecules, and how Hetero is playing a key role in tackling HIV by supporting local players from an API and a technology transfer perspective. Would…
See our Cookie Privacy Policy Here